Zobrazeno 1 - 10
of 273
pro vyhledávání: '"Joris Knoben"'
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-17 (2022)
Abstract Background Interorganizational networks in healthcare do not always attain their goals. Existing models outline the factors that could explain poor network performance: governance; structure; and the alignment of professional, organizational
Externí odkaz:
https://doaj.org/article/d80b0ccfb2ec4434ba3f4de1ebdb84fd
Autor:
James Faulconbridge
Publikováno v:
Growth and Change. 40:552-555
The effects of internal and external innovation strategies on process innovation in Vietnamese firms
Publikováno v:
Asia Pacific Journal of Innovation and Entrepreneurship, Vol 15, Iss 1, Pp 26-38 (2021)
Purpose – This paper aims to investigate the antecedents of process innovation to provide more alternates for Vietnamese firms as they are still struggling to find an appropriate innovation strategy. Design/methodology/approach – The research ana
Externí odkaz:
https://doaj.org/article/604c6493aa52483b8d02238b432245d2
Autor:
Joris Knoben, Dana van den Hurk
Publikováno v:
BMJ Open, Vol 10, Iss 2 (2020)
ObjectivesTo assess whether there is a difference between the net prices of medical products used by Dutch hospitals and, if there is, how this difference can be explained.DesignCross-sectional self-administered electronic survey.SettingWe surveyed t
Externí odkaz:
https://doaj.org/article/a6e7397705d7462ab78b3abc59b4da00
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222443 (2019)
Gender diversity is known to have a positive effect on innovation in developed countries. However, it is unclear whether the benefits of gender diversity for innovation also apply to the particular context of developing countries, which is characteri
Externí odkaz:
https://doaj.org/article/1ee58ddb765f44a79dc34819a86863ba
Publikováno v:
Industry and Innovation, 29(1), 102-130. ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
Industry and Innovation, 29, 102-130
Industry and Innovation, 29, 1, pp. 102-130
Industry and Innovation, 29, 102-130
Industry and Innovation, 29, 1, pp. 102-130
This paper examines how firms in an emerging economy cope with resource challenges by implementing compensation strategies for incremental product innovations. The model is empirically tested using firm-level survey data from 497 South African manufa
Autor:
Faulconbridge, James R.1 j.faulconbridge@lancaster.ac.uk
Publikováno v:
Growth & Change. Sep2009, Vol. 40 Issue 3, p552-555. 4p.
Publikováno v:
Long Range Planning, 55(4):102218. ELSEVIER SCI LTD
Long Range Planning, 55(4):102218. Elsevier Ltd.
Long Range Planning, 55(4):102218. Elsevier Ltd.
We study the dynamics of a major design choice in the governance of ventures: whether to distribute power at the top of the venture between a separate CEO and board chair. We propose that ventures are more likely to combine (separate) their CEO and c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39f66a393e1bf70b062ec88d4cfdeefb
https://research.tilburguniversity.edu/en/publications/7cb927cc-c3a9-49ad-b38e-577ea96042a1
https://research.tilburguniversity.edu/en/publications/7cb927cc-c3a9-49ad-b38e-577ea96042a1
Publikováno v:
Innovation, 23, 1, pp. 93-126
Innovation, 23, 93-126
Innovation: Management, Policy & Practice: the international journal for innovation research, commercialization, policy analysis and best practice, 23(1)
Innovation, 23, 93-126
Innovation: Management, Policy & Practice: the international journal for innovation research, commercialization, policy analysis and best practice, 23(1)
Frugal innovation and related concepts are receiving increasing scholarly attention. While recent progress in the conceptualisation of frugal innovation as a phenomenon has been considerable, insights into the antecedents of frugal innovation remain
Autor:
M. van Houdenhoven, G.E. Léoné-van der Weert, Gert P. Westert, P.J. van der Wees, Joris Knoben
Publikováno v:
Skipr. 13:80-87
De vorming van zorgnetwerken wordt alom gezien als de oplossing voor de fragmentatie van de moderne zorg. In dit artikel onderzoeken we dat ‘medicijn’ op werkzaamheid en bijwerkingen. Een ding is duidelijk: er bestaat geen ‘one size fits all-op